Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 352-359

  Jacobs, E ^b   Watson, S A ^b   Michaeli, D ^c   Ellis, I O ^a   Robertson, J F R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c Aphton Corporation   (United States)

Author keywords

Breast cancer; GnRH; Immunotherapy; Xenograft

Indexed keywords

ANTIBODY; ANTIGEN; DIPHTHERIA TOXOID; ESTROGEN; GONADORELIN; TAMOXIFEN;

ANIMAL MODEL; ARTICLE; ATROPHY; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN BLOOD LEVEL; FEMALE; GENITAL SYSTEM; HUMAN; HUMAN CELL; LUTEINIZING HORMONE BLOOD LEVEL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RABBIT; TUMOR GROWTH; XENOGRAFT;

ANIMALS; ANTIBODIES; CELL DIVISION; FEMALE; GONADOTROPIN-RELEASING HORMONE; GROWTH INHIBITORS; HUMANS; IMMUNIZATION, PASSIVE; LUTEINIZING HORMONE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; ORGAN SIZE; OVARY; RABBITS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERUS;

EID: 0032901532     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690362     Document Type: Article

References (15)

1. Beatson GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet ii: 104-107
2. Blamey RW, Jonat W, Kaufmann M, Raffaele Bianco A and Namer M (1992) Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer 28A: 810-814
3. Cho H, Aronica SM and Katzenellenbogen BS (1994) Regulation of progesterone receptor gene expression in MCF7 breast cancer cells: a comparison of the effects of cyclic adenosine 3′,5′-monophosphate, oestradiol, insulin-like growth factor-I and serum factors. Endocrinology 134: 658-664
4. Dowsett M, Goss PE, Powles TJ, Hulchinson G, Brodie AMH, Jeffcoate SL and Coombes RC (1987) Use of the aromatase inhibitor 4 hydroxyandrostenedione in postmenopausal breast care: optimisation of therapeutic dose and route. Cancer Res 47: 1957-1961
5. Ferro VA and Stimpson WH (1997) Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer. Eur J Cancer 33: 1468-1478
6. Gottardis MM, Robinson SP and Jordan VC (1988) Oestradiol-stimulated growth of MCF7 tumours implanted in athymic mice: a model to study the tumouristatic action of tamoxifen. J Steroid Biochem 30: 311-314
7. Goulding H, Pinder S, Cannon P, Pearson D, Nicholson R, Snead D, Bell J, Elston CW, Robertson JF, Blamey RW and Ellis IO (1995) A new immunohistochemical antibody for the assessment of oestrogen receptor status on routine formalin fixed tissue samples. Hum Pathol 26: 291-294
8. Jacobs E, Watson SA, Hardcastle JD and Robertson JFR (1996) Oestrogen and progesterone receptors in gastrointestinal cancer cell lines. Eur J Cancer 32A: 2348-2353
9. Kraus WL and Katzenellenbogen BS (1993) Regulation or progesterone receptor gene expression and growth in the rat uterus: modulation of oestrogen actions by progesterone and sex steroid hormone antagonists. Endocrinology 132: 2371-2379
10. Lee ET and Desu MM (1972) A computer programme for comparing k samples with right censored data. Comp Progr Biomed 2: 315-321
11. Lett H (1905) An analysis of ninety nine cases of inoperable carcinoma of the breast treated by oophorectomy. Lancet i: 227-228
12. Osborne KC, Hobbs K and Clark GM (1985) Effect of oestrogens and anti-oestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584-590
13. Williams MR, Walker ILJ, Turkes A, Blamey RW and Nicholson RI (1986) The use of LH-RH agonist (ICI 118,630, Zoladex) in advanced premenopausal breast cancer. Br J Cancer 53: 629-636
14. Williamson K, Robertson JFR, Ellis IO, Elston CW, Nicholson RI and Blamey RW (1988) Effect of LHRH agonist, Zoladex® on ovarian histology. Br J Surg 75: 595-596
15. Yano T, Korkut E, Pinski J, Szepeshazi K, Milovanovic S, Groot K, Clarke R, Comaru-Schally AM and Schally AV (1992) Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH. Br Cancer Res Treat 21: 35-45